-
1
-
-
84887102623
-
Glioblastoma and other malignant gliomas: A clinical review
-
Omuro A, DeAngelis LM. Glioblastoma and other malignant gliomas: a clinical review. JAMA. 2013;310:1842-1850.
-
(2013)
JAMA
, vol.310
, pp. 1842-1850
-
-
Omuro, A.1
DeAngelis, L.M.2
-
2
-
-
33747204065
-
The IL-4 and IL-13 pseudomonas exotoxins: New hope for brain tumor therapy
-
Shimamura T, Husain SR, Puri RK. The IL-4 and IL-13 pseudomonas exotoxins: new hope for brain tumor therapy. Neurosurg Focus. 2006;20:E11.
-
(2006)
Neurosurg Focus.
, vol.20
-
-
Shimamura, T.1
Husain, S.R.2
Puri, R.K.3
-
3
-
-
0028917333
-
Placebo-controlled trial of safety and efficacy of intraoperative controlled delivery by biodegradable polymers of chemotherapy for recurrent gliomas. The Polymer-brain Tumor Treatment Group
-
Brem H, Piantadosi S, Burger PC, et al. Placebo-controlled trial of safety and efficacy of intraoperative controlled delivery by biodegradable polymers of chemotherapy for recurrent gliomas. The Polymer-brain Tumor Treatment Group. Lancet. 1995;345:1008-1012.
-
(1995)
Lancet.
, vol.345
, pp. 1008-1012
-
-
Brem, H.1
Piantadosi, S.2
Burger, P.C.3
-
4
-
-
1442282498
-
Convection-enhanced delivery of paclitaxel for the treatment of recurrent malignant glioma: A phase I/II clinical study
-
Lidar Z, Mardor Y, Jonas T, et al. Convection-enhanced delivery of paclitaxel for the treatment of recurrent malignant glioma: a phase I/II clinical study. J Neurosurg. 2004;100:472-479.
-
(2004)
J Neurosurg.
, vol.100
, pp. 472-479
-
-
Lidar, Z.1
Mardor, Y.2
Jonas, T.3
-
5
-
-
1342287143
-
Long term survival in a patient with recurrent malignant glioma treated with intratumoral infusion of an IL4-targeted toxin (NBI-3001)
-
Rainov NG, Heidecke V. Long term survival in a patient with recurrent malignant glioma treated with intratumoral infusion of an IL4-targeted toxin (NBI-3001). J Neurooncol. 2004;66:197-201.
-
(2004)
J Neurooncol.
, vol.66
, pp. 197-201
-
-
Rainov, N.G.1
Heidecke, V.2
-
6
-
-
78149479157
-
Phase III randomized trial of CED of IL13-PE38QQR vs Gliadel wafers for recurrent glioblastoma
-
Kunwar S, Chang S, Westphal M, et al. Phase III randomized trial of CED of IL13-PE38QQR vs Gliadel wafers for recurrent glioblastoma. Neuro Oncol. 2010;12:871-881.
-
(2010)
Neuro Oncol.
, vol.12
, pp. 871-881
-
-
Kunwar, S.1
Chang, S.2
Westphal, M.3
-
7
-
-
33947547455
-
Direct intracerebral delivery of cintredekin besudotox (IL13-PE38QQR) in recurrent malignant glioma: A report by the Cintredekin Besudotox Intraparenchymal Study Group
-
Kunwar S, Prados MD, Chang SM, et al. Direct intracerebral delivery of cintredekin besudotox (IL13-PE38QQR) in recurrent malignant glioma: a report by the Cintredekin Besudotox Intraparenchymal Study Group. J Clin Oncol. 2007;25:837-844.
-
(2007)
J Clin Oncol.
, vol.25
, pp. 837-844
-
-
Kunwar, S.1
Prados, M.D.2
Chang, S.M.3
-
8
-
-
78651338682
-
Effect of imaging and catheter characteristics on clinical outcome for patients in the PRECISE study
-
Mueller S, Polley MY, Lee B, et al. Effect of imaging and catheter characteristics on clinical outcome for patients in the PRECISE study. J Neurooncol. 2011;101:267-277.
-
(2011)
J Neurooncol.
, vol.101
, pp. 267-277
-
-
Mueller, S.1
Polley, M.Y.2
Lee, B.3
-
9
-
-
33744787595
-
Real-time, image-guided, convectionenhanced delivery of interleukin 13 bound to pseudomonas exotoxin
-
Murad GJ, Walbridge S, Morrison PF, et al. Real-time, image-guided, convectionenhanced delivery of interleukin 13 bound to pseudomonas exotoxin. Clin Cancer Res. 2006;12:3145-3151.
-
(2006)
Clin Cancer Res.
, vol.12
, pp. 3145-3151
-
-
Murad, G.J.1
Walbridge, S.2
Morrison, P.F.3
-
10
-
-
0035871986
-
Interleukin-13 receptor as a unique target for anti-glioblastoma therapy
-
Husain SR, Joshi BH, Puri RK. Interleukin-13 receptor as a unique target for anti-glioblastoma therapy. Int J Cancer. 2001;92:168-175.
-
(2001)
Int J Cancer.
, vol.92
, pp. 168-175
-
-
Husain, S.R.1
Joshi, B.H.2
Puri, R.K.3
-
11
-
-
16544381261
-
Distribution kinetics of targeted cytotoxin in glioma by bolus or convection-enhanced delivery in a murine model
-
Kawakami K, Kawakami M, Kioi M, Husain SR, Puri RK. Distribution kinetics of targeted cytotoxin in glioma by bolus or convection-enhanced delivery in a murine model. J Neurosurg. 2004;101:1004-1011.
-
(2004)
J Neurosurg.
, vol.101
, pp. 1004-1011
-
-
Kawakami, K.1
Kawakami, M.2
Kioi, M.3
Husain, S.R.4
Puri, R.K.5
-
12
-
-
17844401189
-
Evidence that IL-13R alpha2 chain in human glioma cells is responsible for the antitumor activity mediated by receptor-directed cytotoxin therapy
-
Kawakami K, Kioi M, Liu Q, Kawakami M, Puri RK. Evidence that IL-13R alpha2 chain in human glioma cells is responsible for the antitumor activity mediated by receptor-directed cytotoxin therapy. J Immunother. 2005;28:193-202.
-
(2005)
J Immunother.
, vol.28
, pp. 193-202
-
-
Kawakami, K.1
Kioi, M.2
Liu, Q.3
Kawakami, M.4
Puri, R.K.5
-
14
-
-
0037112434
-
Convection-enhanced delivery of boronated epidermal growth factor for molecular targeting of EGF receptor-positive gliomas
-
Yang W, Barth RF, Adams DM, et al. Convection-enhanced delivery of boronated epidermal growth factor for molecular targeting of EGF receptor-positive gliomas. Cancer Res. 2002;62:6552-6558.
-
(2002)
Cancer Res.
, vol.62
, pp. 6552-6558
-
-
Yang, W.1
Barth, R.F.2
Adams, D.M.3
-
15
-
-
27144433228
-
Resolution, sensitivity and precision with autoradiography and small animal positron emission tomography: Implications for functional brain imaging in animal research
-
Schmidt KC, Smith CB. Resolution, sensitivity and precision with autoradiography and small animal positron emission tomography: implications for functional brain imaging in animal research. Nucl Med Biol. 2005;32:719-725.
-
(2005)
Nucl Med Biol.
, vol.32
, pp. 719-725
-
-
Schmidt, K.C.1
Smith, C.B.2
-
16
-
-
34547500147
-
Clinical utility of a patient-specific algorithm for simulating intracerebral drug infusions
-
Sampson JH, Raghavan R, Brady ML, et al. Clinical utility of a patient-specific algorithm for simulating intracerebral drug infusions. Neuro-oncol. 2007;9:343-353.
-
(2007)
Neuro-oncol.
, vol.9
, pp. 343-353
-
-
Sampson, J.H.1
Raghavan, R.2
Brady, M.L.3
-
17
-
-
77950930742
-
Of mice and humans: Are they the same? Implications in cancer translational research
-
de Jong M, Maina T. Of mice and humans: are they the same? Implications in cancer translational research. J Nucl Med. 2010;51:501-504.
-
(2010)
J Nucl Med.
, vol.51
, pp. 501-504
-
-
De Jong, M.1
Maina, T.2
-
18
-
-
14844341937
-
Current status of therapy of solid tumors: Brain tumor therapy
-
Zalutsky MR. Current status of therapy of solid tumors: brain tumor therapy. J Nucl Med. 2005;46(suppl 1):151S-156S.
-
(2005)
J Nucl Med.
, vol.46
, Issue.SUPPL. 1
-
-
Zalutsky, M.R.1
|